These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 19542259

  • 1. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
    Hasegawa N, Nishimura T, Ohtani S, Takeshita K, Fukunaga K, Tasaka S, Urano T, Ishii K, Miyairi M, Ishizaka A.
    Chest; 2009 Dec; 136(6):1569-1575. PubMed ID: 19542259
    [Abstract] [Full Text] [Related]

  • 2. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y, Yoshida K, Miyashita N, Niki Y, Oka M.
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [Abstract] [Full Text] [Related]

  • 3. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.
    Am J Respir Crit Care Med; 2015 Jan 01; 191(1):96-103. PubMed ID: 25393520
    [Abstract] [Full Text] [Related]

  • 4. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T, Matsui H, Hirose T, Suzuki J, Saito M, Akaba T, Kobayashi K, Akashi S, Kawashima M, Tamura A, Nagai H, Akagawa S, Kobayashi N, Ohta K.
    BMC Infect Dis; 2016 Jan 27; 16():31. PubMed ID: 26818764
    [Abstract] [Full Text] [Related]

  • 5. [Perspective of pulmonary MAC infection treatment].
    Kurashima A.
    Kekkaku; 2007 Mar 27; 82(3):195-9. PubMed ID: 17444124
    [Abstract] [Full Text] [Related]

  • 6. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
    Fujita M, Kajiki A, Tao Y, Miyazaki M, Ouchi H, Harada E, Ikegame S, Matsumoto T, Uchino J, Watanabe K, Nakanishi Y.
    J Infect Chemother; 2012 Apr 27; 18(2):146-51. PubMed ID: 21927844
    [Abstract] [Full Text] [Related]

  • 7. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
    Kobashi Y, Okimoto N, Matsushima T, Shigetou E, Kuraoka T, Takeyama H, Eda R, Yano S, Kobayashi K, Ohnishi T, Mori K, Ueda Y, Moritaka T, Nishimura K, Abe T.
    Kekkaku; 2002 Jun 27; 77(6):435-41. PubMed ID: 12136597
    [Abstract] [Full Text] [Related]

  • 8. The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.
    Kadota JI, Kurashima A, Suzuki K.
    J Infect Chemother; 2017 May 27; 23(5):293-300. PubMed ID: 28254517
    [Abstract] [Full Text] [Related]

  • 9. Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol.
    Nakagawa T, Hashimoto H, Yagi M, Kogure Y, Sekimizu M, Saito AM, Ogawa K, Inoue Y.
    BMJ Open Respir Res; 2019 May 27; 6(1):e000434. PubMed ID: 31258920
    [Abstract] [Full Text] [Related]

  • 10. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
    Sato K, Ebe T.
    Kekkaku; 2000 Jul 27; 75(7):471-6. PubMed ID: 10944891
    [Abstract] [Full Text] [Related]

  • 11. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
    Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A.
    Am J Respir Crit Care Med; 2006 Jun 01; 173(11):1283-9. PubMed ID: 16514112
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S, Shirai M, Toyoshima M, Shirai T, Yasuda K, Yokomura K, Yamada T, Masuda M, Inui N, Chida K, Suda T, Hayakawa H.
    Ann Am Thorac Soc; 2014 Jan 01; 11(1):23-9. PubMed ID: 24298907
    [Abstract] [Full Text] [Related]

  • 13. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y, Tsuyuguchi K, Kobayashi T, Kurahara Y, Yoshida S, Kagawa T, Hayashi S, Suzuki K.
    J Infect Chemother; 2020 Jul 01; 26(7):676-680. PubMed ID: 32171660
    [Abstract] [Full Text] [Related]

  • 14. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
    Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ.
    Clin Infect Dis; 2000 Feb 01; 30(2):288-92. PubMed ID: 10671330
    [Abstract] [Full Text] [Related]

  • 15. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
    Kobashi Y, Matsushima T.
    Intern Med; 2003 Aug 01; 42(8):670-5. PubMed ID: 12924489
    [Abstract] [Full Text] [Related]

  • 16. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ, Wu TS, Chiang PC, Lee MH.
    J Microbiol Immunol Infect; 2007 Aug 01; 40(4):342-8. PubMed ID: 17712469
    [Abstract] [Full Text] [Related]

  • 17. [Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients].
    Kuwabara K, Tsuchiya T.
    Nihon Kokyuki Gakkai Zasshi; 2007 Aug 01; 45(8):587-92. PubMed ID: 17763685
    [Abstract] [Full Text] [Related]

  • 18. Impact of rifampicin on the pharmacokinetics of clarithromycin and 14-hydroxy clarithromycin in patients with multidrug combination therapy for pulmonary Mycobacterium avium complex infection.
    Iketani O, Komeya A, Enoki Y, Taguchi K, Uno S, Uwamino Y, Matsumoto K, Kizu J, Hasegawa N.
    J Infect Chemother; 2022 Jan 01; 28(1):61-66. PubMed ID: 34706852
    [Abstract] [Full Text] [Related]

  • 19. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
    Lee G, Lee KS, Moon JW, Koh WJ, Jeong BH, Jeong YJ, Kim HJ, Woo S.
    Ann Am Thorac Soc; 2013 Aug 01; 10(4):299-306. PubMed ID: 23952847
    [Abstract] [Full Text] [Related]

  • 20. Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
    Koh WJ, Jeong BH, Jeon K, Park HY, Kim SY, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL.
    Antimicrob Agents Chemother; 2015 Aug 01; 59(8):4994-6. PubMed ID: 25987622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.